| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/21/1998 | CN1037104C Novel cyclosporins |
| 01/20/1998 | US5710324 Inhibitors of nitric oxide biosynthesis |
| 01/20/1998 | US5710266 Nucleic acid encoding an interleukin 4 signal transducer |
| 01/20/1998 | US5710265 Genetic engineering; polypeptides |
| 01/20/1998 | US5710262 Nucleic acid encoding HB15 polypeptides |
| 01/20/1998 | US5710257 Method of causing selective immunosuppression using HL-60-related lectins |
| 01/20/1998 | US5710254 Purification of von Willebrand factor by affinity chromatography |
| 01/20/1998 | US5710253 Method for decoloring human serum albumin |
| 01/20/1998 | US5710249 Amino acids and processes for making peptides using same |
| 01/20/1998 | US5710247 Process and intermediates for the synthesis of LHRH antagonists |
| 01/20/1998 | US5710246 Coupling oligopeptides; deprotecting |
| 01/20/1998 | US5710244 Derivatized calcitonins |
| 01/20/1998 | US5710178 Aryl- and aryloxyalkanoic acids |
| 01/20/1998 | US5710175 Optionally acylated 1-alkenyl monoglyceride |
| 01/20/1998 | US5710174 Anticoagulants for blood disorders |
| 01/20/1998 | US5710137 Nucleic acids and gene expression for cancer cells |
| 01/20/1998 | US5710136 Inhibition of neovascularization using VEGF-specific oligonucleotides |
| 01/20/1998 | US5710134 Combination of necrosis-inducing substances with substances which are activated by necroses for the selective therapy of tumors and inflammatory disorders |
| 01/20/1998 | US5710131 Protein isolated from extract of hirudo medicinalis (leech) |
| 01/20/1998 | US5710130 Heterocyclic synthetic peptides |
| 01/20/1998 | US5710129 Inhibitors of SH2-mediated processes |
| 01/20/1998 | US5710128 Pharmaceutical compositions of lipopolysaccharide-binding polypeptides |
| 01/20/1998 | US5710127 Use of growth factor IGF-I and/or IGF-II |
| 01/20/1998 | US5710126 T cell epitopes of ryegrass pollen allergen |
| 01/20/1998 | US5710124 Method for combatting bovine mastitis |
| 01/20/1998 | US5710123 Peptide inhibitors of selectin binding |
| 01/20/1998 | US5710035 Human elastase IV |
| 01/20/1998 | US5710026 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
| 01/20/1998 | US5710024 Polynucleotides that encode the calcitonin gene-related peptide receptor coponent factor (HOUNDC44) |
| 01/20/1998 | US5710023 Isolated polynucleotide sequence; genetic engineering |
| 01/20/1998 | US5710022 Nuclear mitotic phosphoprotein |
| 01/20/1998 | US5710019 Human potassium channel 1 and 2 proteins |
| 01/20/1998 | US5710017 DNA encoding a constitutive activator retinoic acid response (CAR) receptor |
| 01/20/1998 | US5710013 Isolated nucleic acid encoding a polyeptide with specified amino acid sequence; medical diagnosis |
| 01/20/1998 | US5710010 Assays for the presence of a mutant EGF receptor |
| 01/20/1998 | US5710001 17q-linked breast and ovarian cancer susceptibility gene |
| 01/20/1998 | US5709999 Germline mutation of human breast and ovarian cancer predisposing gene |
| 01/20/1998 | US5709995 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 01/20/1998 | US5709993 Process for anticoagulation during extracorporeal blood circulation sequentially using citrate or nafamostat and heparin |
| 01/20/1998 | US5709867 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/20/1998 | US5709862 Immunology and antigens |
| 01/20/1998 | US5709861 Compositions for the delivery of antigens |
| 01/20/1998 | US5709860 Induction of cytotoxic T-lymphocyte responses |
| 01/20/1998 | US5709859 Complexes of fusion proteins; antitumor agent; antiinflammatory agents |
| 01/20/1998 | US5709858 To which they are capable of binding; specified amino acid sequences; medical diagnosis |
| 01/20/1998 | US5709853 Method of treatment of atopic disease |
| 01/20/1998 | US5709797 Method of isolating cyclosporins |
| 01/15/1998 | WO1998001757A1 Labelling and selection of molecules |
| 01/15/1998 | WO1998001563A2 Adenovirus e4 proteins for inducing cell death |
| 01/15/1998 | WO1998001555A2 Truncated soluble tumor necrosis factor type-i and type-ii receptors |
| 01/15/1998 | WO1998001554A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001553A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001552A2 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | WO1998001549A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | WO1998001548A1 Oligomerized receptors which affect pathways regulated by transmembrane ligands for elk-related receptor tyrosine kinases |
| 01/15/1998 | WO1998001547A1 INHIBITION OF CHRONIC MYELOGENOUS LEUKEMIC CELL GROWTH BY LIPOSOMAL-ANTISENSE OLIGODEOXY-NUCLEOTIDES TARGETING TO Grb2 OR Crk1 |
| 01/15/1998 | WO1998001538A1 Method of activating dendritic cells |
| 01/15/1998 | WO1998001476A1 Highly synergistic neutralization of hiv through combinations of monoclonal and polyclonal antibodies |
| 01/15/1998 | WO1998001475A1 Growth factor receptor-binding insulin receptor |
| 01/15/1998 | WO1998001474A2 Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth |
| 01/15/1998 | WO1998001470A1 A transcription factor |
| 01/15/1998 | WO1998001468A1 Chondrocyte proteins |
| 01/15/1998 | WO1998001467A2 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | WO1998001465A1 Neuroactive peptide |
| 01/15/1998 | WO1998001462A2 Urogenital carcinoma tlp complex peptides and antibodies thereof |
| 01/15/1998 | WO1998001460A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/15/1998 | WO1998001159A2 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/15/1998 | WO1998001158A2 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 01/15/1998 | WO1998001155A1 Compositions and methods for regulating hiv gene expression |
| 01/15/1998 | WO1998001153A1 Medicinal compositions for extracorporeal blood circulation circuit and method for inhibiting blood coagulation in extracorporeal blood circulation circuit |
| 01/15/1998 | WO1998001152A1 Remedies for eating disturbance |
| 01/15/1998 | WO1998001151A1 Novel use of mk family as hematopoietic factor |
| 01/15/1998 | WO1998001150A1 Interleukin-8 as an antiviral and antitumor agent |
| 01/15/1998 | WO1998001149A2 VARIANTS OF HUMAN CILIARY NEUROTROPHIC FACTOR (hCNTF) WITH A RANGE OF ACTION DIFFERENT FROM THAT OF THE WILD-TYPE MOLECULE |
| 01/15/1998 | WO1998001148A1 Use of papillomavirus e2 protein in treating papillomavirus-infected cells and compositions containing the protein |
| 01/15/1998 | WO1998001147A1 Medicinal cyclosporin-a aerosol solution formulation |
| 01/15/1998 | WO1998001146A1 Preventives/remedies for stomatitis |
| 01/15/1998 | WO1998001145A1 Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/15/1998 | WO1998001102A2 Treatment for itch of chicken pox |
| 01/15/1998 | WO1998001101A2 Methods for the treatment of apolipoprotein e related diseases |
| 01/15/1998 | WO1997046673A3 Inhibition of hiv-1 replication by antisense rna expression |
| 01/15/1998 | WO1997032989A3 Recombinant aav vector-based transduction system and use of same |
| 01/15/1998 | DE19646977A1 Stable dry extract of Hypericum perforatum L., Saint John's wort |
| 01/15/1998 | DE19628705A1 Neue Sauerstoff-Transport-Mittel, diese enthaltende Hämoglobin-Hydroxyethylstärke-Konjugate, Verfahren zu deren Herstellung, sowie deren Verwendung als Blutersatzstoffe New oxygen transfer agent containing them hemoglobin-hydroxyethylstarch conjugates, processes for their preparation, and to their use as blood substitutes |
| 01/15/1998 | CA2741501A1 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to grb2 or crk1 |
| 01/15/1998 | CA2260295A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2260293A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2260183A1 Methods for the treatment of apolipoprotein e related diseases |
| 01/15/1998 | CA2260014A1 Novel use of mk family as hematopoietic factor |
| 01/15/1998 | CA2259957A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259955A1 Secreted proteins and polynucleotides encoding them |
| 01/15/1998 | CA2259618A1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 01/15/1998 | CA2259157A1 Oligomerized receptors which affect pathways regulated by transmembrane ligands for elk-related receptor tyrosine kinases |
| 01/15/1998 | CA2259154A1 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/15/1998 | CA2259149A1 Inhibitors of the interaction between p53 and mdm2 |
| 01/15/1998 | CA2259137A1 Neuroactive peptide |
| 01/15/1998 | CA2258947A1 Haemoglobin-hydroxyethyl starch conjugates as oxygen carriers |
| 01/15/1998 | CA2258697A1 Interleukin-8 as an antiviral and antitumor agent |
| 01/15/1998 | CA2257563A1 Composition for enhanced uptake of polar drugs from mucosal surfaces |
| 01/15/1998 | CA2231328A1 Treatment for itch of chicken pox |